Consultations on Quality Use of Medicines

Follow the links below to find information about consumer consultations and participation in quality use of medicines programs.

Updated October 2007

Printer friendly page

60 Resources Found
Results 1 to 20 displayed.
1    2    3   
Title:   Safety and quality must involve consumers
Publisher:   Consumers' Health Forum of Australia (CHF)
Description:   The Australian Commission on Safety and Quality in Health Care is already contributing to the reform process through its workplan's nine programs. The Commission works with consumers as a major stakeholder in improving safety and quality in health care.
Date:   Jul 2008
Title:   Portrait of a consumer representative - Anne McKenzie
Publisher:   Consumers' Health Forum of Australia (CHF)
Description:   A consumer representative discusses her keen interest in issues relating to the quality use of medicines and how they have affected her life and career.
Date:   Apr 2007
Title:   Consumer Expectations of the Community Quality Use of Medicines Program
Publisher:   Consumers' Health Forum of Australia (CHF)
Description:   This paper discusses the responses to the CHF Member Questionnaire about their preferred method of engagement and participation in the Community Quality Use of Medicines Program.
Date:   Jun 2005
Title:   CHF project to support consumer participation in the community quality use of medicines program
Publisher:   Consumers' Health Forum of Australia (CHF)
Description:   Consultation with members about the Consumers' Health Forum of Australia's (CHF) project contribution to the National Prescribing Service (NPS) Community Quality Use of Medicines Program.
Date:   Jan 2004
Title:   Selling sickness: how drug companies are turning us all into patients
Publisher:   Consumers' Health Forum of Australia (CHF)
Description:   This book prompted the reviewer to question the place of medicines in maintaining health and the latest medical facts and figures presented in the media as news.
Date:   Jan 2006
Title:   Submission to the stakeholder consultation for revision of the Usability Guide for Writing CMI
Publisher:   Consumers' Health Forum of Australia (CHF)
Description:   This submission outlines key issues for consumers relating to Consumer Medicine Information (CMI) and the proposed regulatory changes. CMI is not broadly available for consumers. The sequence and content need continual review but dissemination must be improved as well.
Date:   Feb 2006
Title:   Introducing the Adverse Medicine Events Line
Publisher:   Australian Prescriber
Description:   Consumer reporting of adverse drug reactions has become a reality in Australia with the launch of a telephone hotline called the Adverse Medicine Events (AME) Line. Operated by clinical pharmacists, AME Line allows consumers to seek information about or report adverse events associated with medicines, including adverse drug reactions, errors and near misses.
Date:   Apr 2004
Title:   Consumer Medicine Information (CMI)
Publisher:   Commonwealth Department of Health and Aged Care
Description:   This guide is about consumer medicine information (CMI) and how it can be used by consumers and health professionals to build better relationships and achieve the quality use of medicines.
Date:   Sep 2003
Title:   Report of CHF Medicines Consumer Representatives Meeting - Sydney 5 April 2006
Publisher:   Consumers' Health Forum of Australia (CHF)
Description:   CHF and the National Prescribing Service (NPS) held a meeting for consumer representatives working on medicines committees at a national level.
Date:   Oct 2006
Title:   Guiding principles for medication management in the community
Publisher:   Australian Government Department of Health and Ageing
Description:   These Guiding Principles have been developed by the Australian Pharmaceutical Advisory Council (APAC) with the aim of promoting the quality use of medicines and better medication management in the community.
Date:   Feb 2008
Title:   Consumer Medicine Information conundrums
Publisher:   Australian Prescriber
Description:   Consumer Medicine Information is standardised written information about prescription and pharmacist-only medicines in Australia. It is a tool which can be used by health professionals during their consultations to explain about the treatment they are recommending.
Date:   Oct 2007
Title:   'Take as directed', whatever that means
Publisher:   Australian Prescriber
Description:   Many factors contribute to patients not taking medicines as directed. Australian professional research papers often investigate compliance as an adjunct to other research goals. Consumer research looks at the broader range of factors and issues that might contribute to how consumers use their medicines.
Date:   Jan 2000
Title:   Starter packs: a good start to therapy?
Publisher:   Australian Prescriber
Description:   Samples of drugs are often given to doctors by pharmaceutical representatives as part of a marketing strategy. Despite the well described advantages of drug samples, little has been published on the potential adverse outcomes.
Date:   Feb 2007
Title:   Informing the consumer
Publisher:   Australian Prescriber
Description:   Good communication between medical practitioners and consumers, and between pharmacists and consumers, is vital if the best health outcomes are to be achieved through the use of medicines. The provision of information to consumers about their medication is an important part of that communication.
Date:   Feb 2003
Title:   Review of the labelling requirements for medicines - consumer-focused labelling - a way forward?
Publisher:   Australian Government Department of Health and Ageing
Description:   The TGA is interested in fostering a consumer-focused approach to the labelling of consumer medicines in Australia. A medicine's label is the single most important source of information available to consumers.
Date:   Apr 2002
Title:   Paracetamol: overused in childhood fever - a consumer perspective
Publisher:   Australian Prescriber
Description:   This comment on the article 'Paracetamol: overused in childhood fever' suggests the value of a pharmaceutical campaign which describes the safe and appropriate use of paracetamol in the wider context of childhood illnesses, including information about other measures parents can use to help their child feel more comfortable while recovering.
Date:   Jan 2000
Title:   Click, click: the internet and prescription drugs - a consumer perspective
Publisher:   Australian Prescriber
Description:   There are two of many risks for consumers in obtaining prescription medicines or drug information from the internet. The first risk is the blurring of promotional information with balanced objective information on suppliers' web sites.
Date:   Jan 2000
Title:   Second discussion paper: Improving access to Consumer Medicines Information (CMI) and Product Information (PI)
Publisher:   Australian Government Department of Health and Ageing
Description:   The purpose of this Second Discussion Paper is to seek stakeholder views on some revised options including the TGA's preferred option. The closing date for submissions is 30 March 2007.
Date:   Feb 2007
Title:   Drug company advertising (Comments for Consumers)
Publisher:   Australian Prescriber
Description:   In Australia drug companies are not allowed to advertise prescription medicines directly to the public. This does not prevent them from providing information about the conditions the medicines are used for.
Date:   Feb 2004
Title:   Paracetamol: overused in childhood fever
Publisher:   Australian Prescriber
Description:   Paracetamol has a mild beneficial effect on the symptoms of viral illness in childhood. However, the child may still remain unwell. There are good reasons, particularly related to toxicity, for limiting the use of paracetamol in children.
Date:   Jan 2000
Results 1 to 20 displayed.
1    2    3